No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on schizophrenia
Eric J. Nestler, M.D., Ph.D.
April 01, 1996
With support from a NARSAD Grant in 1996, Eric J. Nestler, M.D., Ph.D., and colleagues identified a novel transcription factor that determines the long-lasting...
Helen Mayberg, M.D. - Brain & behavior research expert on depression
Helen Mayberg, M.D.
December 01, 1991
In 1991, Foundation Scientific Council Member, Helen Mayberg, M.D., pioneered the use of positron emission tomography (PET) brain scanning technology to study...
Herbert Y. Meltzer, M.D. discovers clozapine works for treatment-resistant schizophrenia patients and to help reduce suicide
Herbert Y. Meltzer, M.D.
December 01, 1989
In our second year of grant-giving, 1988, Dr. Herbert Meltzer received a NARSAD Distinguished Investigator Grant to test his idea that clozapine might be a...

Pages

Subscribe to